Skip to content

Company

ARS Pharmaceuticals

United States

The ETFs we cover that hold this company, and its latest news.

Which ETFs hold ARS Pharmaceuticals?

Held by 41 covered funds. Sorted by ARS Pharmaceuticals’ share of each fund. Holdings as of each fund’s latest SEC filing.

FundShare of fund
SBIOALPS Medical Breakthroughs0.6%
XBIState Street(R) SPDR(R) S&P(R) Biotech0.2%
IBBQInvesco Nasdaq Biotechnology0.1%
QOWZInvesco Nasdaq Free Cash Flow Achievers0.1%
ESSCEventide Small Cap0.1%
IBBiShares Biotechnology0.0%
IWOiShares Russell 2000 Growth0.0%
VTWGVanguard Russell 2000 Growth Index Fund0.0%
PWSPacer WealthShield0.0%
RESMColumbia Research Enhanced Small Cap0.0%
VTWOVanguard Russell 2000 Index Fund0.0%
IWMiShares Russell 20000.0%
NSIDXSmall Cap Index Fund0.0%
ITWOProShares Russell 2000 High Income0.0%
RBProShares Russell 2000 Dynamic Buffer0.0%
OMFSInvesco Russell 2000 Dynamic Multifactor0.0%
ISCViShares Morningstar Small-Cap Value0.0%
RSSLGlobal X Russell 20000.0%
AVTMAvantis Total Equity Markets0.0%
SCHASchwab U.S. Small-Cap0.0%
VHTVanguard Health Care Index Fund0.0%
SMLFiShares U.S. Small-Cap Equity Factor0.0%
VXFVanguard Extended Market Index Fund0.0%
SSMHXState Street Small/mid Cap Equity Index Portfolio0.0%
ISCBiShares Morningstar Small-Cap0.0%
FHLCFidelity MSCI Health Care Index0.0%
ONEQFidelity Nasdaq Composite Index0.0%
MSSMMorgan Stanley Pathway Small-Mid Cap Equity0.0%
WSMLiShares MSCI World Small-Cap0.0%
ACIMSPDR(R) Portfolio MSCI Global Stock Market0.0%
DFASDimensional U.S. Small Cap0.0%
TILTFlexShares Morningstar US Market Factor Tilt Index Fund0.0%
DFSCXU.S. Micro Cap Portfolio0.0%
ITOTiShares Core S&P Total U.S. Stock Market0.0%
IWViShares Russell 30000.0%
SCHBSchwab U.S. Broad Market0.0%
VTHRVanguard Russell 3000 Index Fund0.0%
VITPXVanguard Institutional Total Stock Market Index Fund0.0%
VTIVanguard Total Stock Market Index Fund0.0%
KCXSXKnights of Columbus U.S. ALL CAP INDEX FUND0.0%
SSBIXState Street Balanced Index Fund0.0%

Where to buy these ETFs

[Affiliate and risk wording from the law firm]

Latest ARS Pharmaceuticals news

No recent stories about ARS Pharmaceuticals.